Health News Releases

  • Today December 21
April 11, 2018 18:10
HeartSciences Announces Publication of Clinical Study Results in the Journal of the American College of Cardiology (JACC)
HeartSciences, a medical device company leading innovation in electrocardiography through the application of continuous wavelet transform (CWT) signal processing and artificial intelligence, announced
April 11, 2018 12:00
JPT Peptide Technologies Launches The Human Proteome Peptide Catalog
JPT Peptide Technologies (JPT) announces the launch of The Human Proteome Peptide Catalog, the first and most comprehensive online resource for validated reference peptides in mass-spectrometry based
April 10, 2018 19:20
Swiss Advanced Vision Launches Active Intraocular Lens Concept with Real-Time Autofocus for Cataract Surgery
Swiss Advanced Vision (SAV-IOL) has announced the launch of Project R-TASC, set to disrupt the global intraocular lens (IOL) market. Cataracts are responsible for 51% of world blindness, which repr
April 10, 2018 16:55
HeartSciences Showcases MyoVista® Wavelet ECG at 2018 China International Medicinal Equipment Fair (CMEF)
HeartSciences, an innovative medical device company, is proud to announce its participation as an exhibitor at the upcoming 2018 China International Medicinal Equipment Fair (CMEF) Shanghai, China, Ap
April 06, 2018 09:40
Ferring Acquires Innovative Biotechnology Company and Microbiome Pioneer Rebiotix Inc.
Ferring Pharmaceuticals* and Rebiotix Inc. today announce that they have agreed to the acquisition of Rebiotix by Ferring. This acquisition brings together two innovative healthcare companies that sha
April 05, 2018 13:15
Boehringer Ingelheim and OSE Immunotherapeutics Announce Global Immuno-Oncology Partnership to Develop a Pioneering Checkpoint Inhibitor for the Treatment of Advanced Solid Tumors
Boehringer Ingelheim and OSE Immunotherapeutics, a biotechnology company focused on the development of innovative immunotherapies, today announced a collaboration and exclusive worldwide collaboration
April 04, 2018 14:25
Impossible Foods Announces $114 Million Convertible Note as Startup Prepares for Rapid Expansion in the US and Overseas
Impossible Foods announced today the successful closing of about $114 million in convertible note financing. The food technology startup has raised approximately $214 million in the past 18 months
April 03, 2018 13:10
ResMed Hires Bobby Ghoshal as First Chief Technology Officer
ResMed (NYSE: RMD, ASX: RMD) today announced the hire of its first chief technology officer (CTO), Bobby Ghoshal, effective today. As CTO, Ghoshal will lead ResMed’s global healthcare informatics a
April 02, 2018 15:00
PharmAbcine Announces FDA Orphan Drug Designation Granted to TTAC-0001 for Glioblastoma Multiforme
PharmAbcine Inc., a clinical-stage biotech company developing novel antibody therapeutics for multiple cancer indications, announced today that U.S. Food and Drug Administration (FDA) has granted orph
March 30, 2018 14:25
Final results from landmark DYNAGITO® trial published in The Lancet Respiratory Medicine[1]
Boehringer Ingelheim today announced data from the landmark 52-week DYNAGITO® trial which show that in people with COPD (chronic obstructive pulmonary disease), Spiolto® Respimat® (tiotropium/olodater
March 30, 2018 11:50
Toshiba Heavy-Ion Therapy System Awarded by Yonsei University Health System
Toshiba Energy Systems & Solutions Corporation (Toshiba ESS), a world leader in heavy-ion therapy system, in collaboration as a consortium with DK Medical Solutions, a Korean leading global medical co
March 27, 2018 09:55
Three Leading Animal Health Companies Join Hands to Launch World-Class Vaccine Joint Venture Targeting Foot-and-Mouth Disease in China
Shaanxi Meili Omni-Honesty Animal Health Co., Ltd., China’s world-class vaccine company targeting foot-and-mouth disease in swine, was launched on March 24th with a groundbreaking ceremony held at the
March 26, 2018 15:30
Takeda Announces Publication of Final Data from ICLUSIG® (ponatinib) Pivotal Phase 2 PACE Trial in Blood
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that final data from the pivotal Phase 2 PACE clinical trial of ICLUSIG (ponatinib) in refractory chronic myeloid leukemia (CML) or Ph
March 26, 2018 11:30
Janssen Announces Positive CHMP Opinion for JULUCA™▼ (dolutegravir/rilpivirine)
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Op
March 22, 2018 15:45
Morinaga Milk‘s New Probiotic Strain, Bifidobacterium breve A1, May Prevent Onset of Alzheimer’s Disease
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced the results of a new study investigating the preventive effects of its new probiotic strain Bif
March 21, 2018 13:05
Favorable safety profile of Pradaxa® (dabigatran etexilate) confirmed in large prospective real-world analysis
New data from one of the largest prospective ongoing global studies examining the use of oral antithrombotics for stroke prevention in atrial fibrillation (AF) in clinical practice, GLORIA™-AF, were p
March 20, 2018 11:30
FDA grants Fast Track designation to nintedanib for the treatment of systemic sclerosis with associated interstitial lung disease
Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to nintedanib for the treatment of systemic sclerosis with associated interstit
March 16, 2018 16:40
Nocturia: the most common cause of a poor night’s sleep, say experts on World Sleep Day
On World Sleep Day, scientists are highlighting the number one reason that people are waking up at night - nocturia (otherwise known as the need to get up and urinate more than once during the night).
March 15, 2018 17:10
Ferring Announces Positive Outcome of European Decentralised Procedure (DCP) for Testavan®, a Treatment for Men with Hypogonadism
Ferring Pharmaceuticals today announced the positive outcome of the European Decentralised Procedure (DCP) for Testavan® (transdermal testosterone gel 2%), a testosterone replacement therapy for adult
March 13, 2018 13:20
New Study Investigates the Performance of Masimo SpHb® During Acute Bleeding and After Fluid Resuscitation
Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Cairo University in Egypt evaluated the accuracy and trending of Masimo noninvasive and continu
March 07, 2018 15:35
Historic Student Exchange Programme Agreed between Konkuk University, Seoul, and St George’s University, Grenada
Konkuk University in Seoul, South Korea, has signed an agreement with St George’s University, Grenada, to enable students of Veterinary Medicine from each university to enter a one-year exchange progr
March 07, 2018 15:15
March of Dimes and Ferring Announce New Prematurity Research Center at Imperial College London
March of Dimes and Ferring Pharmaceuticals today announced that March of Dimes has selected Imperial College London as the first European partner to join its network of Prematurity Research Centers wo
March 07, 2018 13:25
Boehringer Ingelheim and Lilly expand heart failure programme for empagliflozin with new exercise capacity trials
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced plans to expand their clinical trial programme for empagliflozin in chronic heart failure with the EMPERIAL clinical trials.
March 06, 2018 17:55
Boehringer Ingelheim Starts New Campaign: ‘Why wait in IPF?’
On Rare Disease Day, 28 February, Boehringer Ingelheim emphasises the question: ‘Why wait in IPF?´ while awareness activities are focussing on highlighting the benefits of early diagnosis and consider
March 05, 2018 14:35
Octapharma Group Publishes 2017 Annual Results Reporting Revenue of €1.72 Billion and Operating Income of €349 Million
Over the last six years, the Octapharma Group has accomplished a remarkable compound annual growth rate of 15% and reports another record-breaking result for 2017, with sales of €1.72 billion - €120 m
25 per page50 per page75 per page100 per page